fraxinellone has been researched along with Colitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, G; Feng, LL; Guo, WJ; Ouyang, ZJ; Shen, Y; Sun, Y; Wu, XD; Wu, XF; Xu, Q | 1 |
1 other study(ies) available for fraxinellone and Colitis
Article | Year |
---|---|
Suppression of NF-κB signaling and NLRP3 inflammasome activation in macrophages is responsible for the amelioration of experimental murine colitis by the natural compound fraxinellone.
Topics: Animals; Benzofurans; Cell Line; Colitis; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inflammasomes; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction | 2014 |